CohBar to Present at the BIO-Europe Conference
MENLO PARK, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria […]
Enstar Completes First Insurance Business Transfer Transaction in the U.S.
HAMILTON, Bermuda, Oct. 15, 2020 (GLOBE NEWSWIRE) — Enstar Group Limited (NASDAQ: ESGR) (“Enstar”) today announced that it has successfully […]
Atomera to Announce Financial Results and Host Third Quarter 2020 Conference Call & Webcast on Thursday, October 29, 2020
LOS GATOS, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) — Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and intellectual property licensing […]
CDK Global to Announce First Quarter Fiscal 2021 Financial Results on November 2, 2020
HOFFMAN ESTATES, Ill., Oct. 15, 2020 (GLOBE NEWSWIRE) — CDK Global, Inc. (Nasdaq: CDK), a leading retail automotive technology company, […]
Marten Transport Announces Third Quarter Results
MONDOVI, Wis., Oct. 15, 2020 (GLOBE NEWSWIRE) — Marten Transport, Ltd. (Nasdaq/GS:MRTN) today reported an 8.8% improvement in net income […]
Millicom announces the refinancing of its Revolving Credit Facility with a new $600 million ESG-Linked Facility
Millicom announces the refinancing of its Revolving Credit Facility with a new $600 million ESG-Linked Facility Luxembourg, October 15, 2020 – […]
Zynerba Pharmaceuticals Presents Data Supporting FMR1 Methylation Status as a Correlate to Fragile X Syndrome Severity at the Virtual Joint 16th International Child Neurology Congress (ICNC) & 49th Annual Child Neurology Society (CNS) Meeting
DEVON, Pa., Oct. 15, 2020 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies […]
New Data Describing Statistically Significant Results from the Phase 2 BRIGHT Trial in Patients with Autism Spectrum Disorder (ASD) Presented at the Virtual Joint 16th International Child Neurology Congress (ICNC) & 49th Annual Child Neurology Society (CNS) Meeting
DEVON, Pa., Oct. 15, 2020 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies […]
